The reported impact of non-communicable disease investment cases in 13 countries
-
Published:2024-04
Issue:4
Volume:9
Page:e014784
-
ISSN:2059-7908
-
Container-title:BMJ Global Health
-
language:en
-
Short-container-title:BMJ Glob Health
Author:
Troisi GiuseppeORCID, Small Roy, Chestnov Roman, Andreasyan Diana, Khachatryan Henrik, Phillips Erwin Arthur, Malcolm Taraleen, Kol Hero, Khodjaeva Nargiza, Gebremichael Mussie, Worku Tessema Addisu, Workneh Asmamaw Bezabeh, Davidson Tamu, Harris Michelle, Ibraeva Nurgul, Nurmatova Aigul, Altymysheva Aliina, Go John Juliard, Kontsevaya Anna, Hanbunjerd Krisada, Bunluesin Sushera, Nieveras Olivia, Ekinci BanuORCID, Keskinkiliç Bekir, Erguder Toker, Akiya Oyoo Charles, Kasule Hafisa, Nakanjako Aidah, Shukurov Shukhrat, Kasymova Nazokat, Banda Patrick, Kakoma Ernest, Bakyaita Nathan N, Kulikov Alexey, Tarlton Dudley, Putoud Nadia, Chiossi Scott, Webb DouglasORCID, Banatvala Nicholas
Abstract
Non-communicable diseases (NCDs) are a leading health and development challenge worldwide. Since 2015, WHO and the United Nations Development Programme have provided support to governments to develop national NCD investment cases to describe the socioeconomic dimensions of NCDs. To assess the impact of the investment cases, semistructured interviews and a structured process for gathering written feedback were conducted between July and October 2022 with key informants in 13 countries who had developed a national NCD investment case between 2015 and 2020. Investment cases describe: (1) the social and economic costs of NCDs, including their distribution and projections over time; (2) priority areas for scaled up action; (3) the cost and returns from investing in WHO-recommended measures to prevent and manage NCDs; and (4) the political dimensions of NCD responses. While no country had implemented all the recommendations set out in their investment case reports, actions and policy changes attributable to the investment cases were identified, across (1) governance; (2) financing; and (3) health service access and delivery. The pathways of these changes included: (1) stronger collaboration across government ministries and partners; (2) advocacy for NCD prevention and control; (3) grounding efforts in nationally owned data and evidence; (4) developing mutually embraced ‘language’ across health and finance; and (5) elevating the priority accorded to NCDs, by framing action as an investment rather than a cost. The assessment also identified barriers to progress on the investment case implementation, including the influence of some private sector entities on sectors other than health, the impact of the COVID-19 pandemic, and changes in senior political and technical government officials. The results suggest that national NCD investment cases can significantly contribute to catalysing the prevention and control of NCDs through strengthening governance, financing, and health service access and delivery.
Funder
World Health Organization, United Nations Development Programme, Government of the Russian Federation
Reference15 articles.
1. World Health Organization . Global Health Estimates 2019: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. Geneva, Switzerland, 2020. Available: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death 2. The short-term effect of BMI, alcohol use, and related chronic conditions on labour market outcomes: a time-lag panel analysis utilizing European SHARE data-set;Feigl;PLoS ONE,2019 3. World Health Organization and United Nations Development Programme . Guidance Note on the Integration of Noncommunicable Diseases into the United Nations Development Assistance Framework. Geneva, Switzerland, 2015. 4. World Health Organization . Tackling NCDs - “best buys” and other recommended interventions for the prevention and control of noncommunicable diseases. Geneva, Switzerland, 2017. 5. Banatvala N , Bovet P , Isaranuwatchai W , et al . Best BUYS and other recommended interventions for NCD prevention and control. In: Noncommunicable Diseases: A Compendium. Ed Nick Banatvala and Pascal Bovet. Oxford, UK: Routledge, 2013.
|
|